Adherence with statins in a real-life setting is better when associated cardiovascular risk factors increase: a cohort study

Table 3 adherence to statin treatment for new users

Type of indicator	Parameters	One risk factor (statin alone)	Two risk factors*	At least three risk factors*
	n=	3,560	5,072	7,765
Medication availability	CMA, mean % [CI₉₅]	56 [54.7;57.2]	64.4 [63.4;65.5]	72.2 [71.9;73.6]
	CMA < 80%, n (%)	2,378 (67.0)	2,889 (57.0)	3,361 (43.3)
Persistence	Cumulative rate for persistence at 15 months % [CI₉₅]	44.3 [42.7;45.9]	50.1 [48.7;51.5]	59.4 [58.3;60.5]
Regularity	CMG, mean % [CI₉₅]	33.4 [32.5;34.3]	29.2 [28.5;29.9]	23.2 [22.7;23.8]
Refill delay	mean [CI₉₅], days	31.4 [31.0;31.8]	30.2 [29.9;30.5]	28.6 [28.3;28.8]

CMA: Continuous Multiple-interval measures of medication Availability; CMG: Continuous Multiple-interval measures of medication Gaps.
*: other risk factors include age, diabetes mellitus and cardiovascular co-morbidities

ISSN: 1471-2261